BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38625920)

  • 1. Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden.
    Talani C; Högmo A; Laurell G; Mäkitie A; Farnebo L
    PLoS One; 2024; 19(4):e0296534. PubMed ID: 38625920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study.
    Talani C; Mäkitie A; Beran M; Holmberg E; Laurell G; Farnebo L
    PLoS One; 2019; 14(10):e0223154. PubMed ID: 31577831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
    Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.
    Jouhi L; Halme E; Irjala H; Saarilahti K; Koivunen P; Pukkila M; Hagström J; Haglund C; Lindholm P; Hirvikoski P; Vaittinen S; Ellonen A; Tikanto J; Blomster H; Laranne J; Grénman R; Mäkitie A; Atula T
    Acta Oncol; 2018 Apr; 57(4):541-551. PubMed ID: 29145765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of remoteness of residence on timeliness of diagnosis and treatment of oral cavity and oropharynx cancer: A retrospective cohort study.
    Venchiarutti RL; Clark JR; Palme CE; Shakespare TP; Hill J; Tahir ARM; Dwyer P; Young JM
    J Med Imaging Radiat Oncol; 2020 Apr; 64(2):261-270. PubMed ID: 32037663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
    Maggiore RJ; Curran EK; Witt ME; Haraf DJ; Vokes EE; Cohen EE
    J Geriatr Oncol; 2013 Oct; 4(4):327-33. PubMed ID: 24472475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent has the last two decades seen significant progress in the management of older patients with head and neck cancer?
    van der Kamp MF; van Dijk BAC; Plaat BEC; van der Laan BFAM; Halmos GB
    Eur J Surg Oncol; 2021 Jun; 47(6):1398-1405. PubMed ID: 33648773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of palliative care in relapsed and metastatic head and neck cancer patients in a single ESMO integrated oncology and palliative care centre.
    Espeli VG; Fusi-Schmidhauser T; Mangan D; Gamondi C
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5897-5902. PubMed ID: 35821270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
    Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
    Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
    Westergren DO; Gårdmark T; Lindhagen L; Chau A; Malmström PU
    J Urol; 2019 Nov; 202(5):905-912. PubMed ID: 31144594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma of the mobile tongue in young adults: A Swedish head & neck cancer register (SweHNCR) population-based analysis of prognosis in relation to age and stage.
    Jonasson K; Sjövall J; Holmberg E; Beran M; Niklasson M; Kristiánsson S; Sandström K; Wennerberg J
    Oral Oncol; 2023 Sep; 144():106485. PubMed ID: 37451141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.
    Brouwer AF; He K; Chinn SB; Mondul AM; Chapman CH; Ryser MD; Banerjee M; Eisenberg MC; Meza R; Taylor JMG
    Cancer; 2020 Dec; 126(23):5137-5146. PubMed ID: 32888317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship.
    Massa ST; Chidambaram S; Luong P; Graboyes EM; Mazul AL
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1111-1119. PubMed ID: 36264567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.